1. Home
  2. DAIO vs CTXR Comparison

DAIO vs CTXR Comparison

Compare DAIO & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$3.92

Market Cap

37.9M

Sector

Industrials

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.58

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
CTXR
Founded
1969
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
18.9M
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
DAIO
CTXR
Price
$3.92
$0.58
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$5.22
$6.00
AVG Volume (30 Days)
144.5K
367.0K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.38
EPS
N/A
N/A
Revenue
$21,500,000.00
N/A
Revenue This Year
$4.51
N/A
Revenue Next Year
$30.29
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.16
$0.48
52 Week High
$4.49
$2.24

Technical Indicators

Market Signals
Indicator
DAIO
CTXR
Relative Strength Index (RSI) 59.81 45.13
Support Level $2.89 $0.57
Resistance Level $4.10 $0.74
Average True Range (ATR) 0.28 0.04
MACD -0.05 0.00
Stochastic Oscillator 68.91 46.82

Price Performance

Historical Comparison
DAIO
CTXR

About DAIO Data I/O Corporation

Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: